期刊文献+

Interferon related pericarditis:Review

Interferon related pericarditis: Review
下载PDF
导出
摘要 AIM To conduct a review of "interferon related pericarditis". METHODS We searched MEDLINE, EMBASE, Cinahl, and the Co-chrane Database from the earliest available date through September 2016. A search strategy using the Medical Subject Headings and text keywords "interferon" and "pericarditis" were used. RESULTS Nine case reports were eligible for the present study. Six of 8 cases were women and the mean age was 43.8 ± 13.8 years with chronic hepatitis C in 6 cases, malignant melanoma in 2 cases and chronic myelogenous leukemia in 1 case. The patients complained of chest pain in 6 cases, dyspnea in 5 cases and edema in 2 cases. Pericardial friction rub was heard in 3 of 9 cases. Congestive heart failure occurred in 3 of 9 cases. Two mechanisms for pericarditis were demonstrated, one is autoimmune included lupus like syndrome in 2 cases and the other is cardio toxicity in 4 cases. Treatment of interferon related pericarditis is discontinuation of Interferon treatment. Four of 9 cases were treated with prednisone and 4 with nonsteroidal anti-inflammatory drugs. CONCLUSION Interferon related pericarditis still remains uncertain. Treatment of interferon related pericarditis rests mainly on early recognition and drug discontinuation. Interferon related pericarditis was treated with steroid and/or nonsteroidal anti-inflammatory drugs. AIMTo conduct a review of “interferon related pericarditis”. METHODSWe searched MEDLINE, EMBASE, Cinahl, and the Cochrane Database from the earliest available date through September 2016. A search strategy using the Medical Subject Headings and text keywords “interferon” and ”pericarditis” were used. RESULTSNine case reports were eligible for the present study. Six of 8 cases were women and the mean age was 43.8 ± 13.8 years with chronic hepatitis C in 6 cases, malignant melanoma in 2 cases and chronic myelogenous leukemia in 1 case. The patients complained of chest pain in 6 cases, dyspnea in 5 cases and edema in 2 cases. Pericardial friction rub was heard in 3 of 9 cases. Congestive heart failure occurred in 3 of 9 cases. Two mechanisms for pericarditis were demonstrated, one is autoimmune included lupus like syndrome in 2 cases and the other is cardio toxicity in 4 cases. Treatment of interferon related pericarditis is discontinuation of Interferon treatment. Four of 9 cases were treated with prednisone and 4 with nonsteroidal anti-inflammatory drugs. CONCLUSIONInterferon related pericarditis still remains uncertain. Treatment of interferon related pericarditis rests mainly on early recognition and drug discontinuation. Interferon related pericarditis was treated with steroid and/or nonsteroidal anti-inflammatory drugs.
出处 《World Journal of Cardiology》 CAS 2017年第6期553-557,共5页 世界心脏病学杂志(英文版)(电子版)
  • 相关文献

参考文献1

二级参考文献27

  • 1Teragawa H.Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C,1996.
  • 2A. Boonen,R. W. Stockbrügger,Sj. van der Linden.Pericarditis After Therapy with Interferon-α for Chronic Hepatitis C[J]. Clinical Rheumatology . 1999 (2)
  • 3Wisniewski B,Denis J,Fischer D,Labayle D.[Pericarditis secondary to interferon alpha in chronic hepatitis C]. Gastroenterologie Clinique et Biologique . 2004
  • 4Gressens B,Gohy P.Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gas-troenterol Belg . 2004
  • 5Benjamini O,Kimhi O,Lishner M.Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. The Israel Medical Association Journal . 2007
  • 6Hamdani I,Kochlef A,Belhadj N,Kharrat J,Ghorbel A.[Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A]. Tunisie Medicale . 2008
  • 7Hirotani M,Nakano H,Ura S,Yoshida K,Niino M,Yabe I,Sasaki H.Chronic inflammatory demyelinating polyneu-ropathy after treatment with interferon-alpha. Journal of Internal Medicine . 2009
  • 8Mansat-Krzyzanowska E,Dréno B,Chiffoleau A,Litoux P.[Cardiovascular manifestations associated with interferon alfa- 2A]. .
  • 9Téllez-Zenteno JF,Negrete-Pulido O,Nu?ez M,Esta?ol-Vidal B,García-Ramos G.[Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C,and a review of the literature]. Revue Neurologique . 2002
  • 10Lin W,Kemper A,Dupree JL,Harding HP,Ron D,Popko B.Interferon-gamma inhibits central nervous system remye-lination through a process modulated by endoplasmic reticu-lum stress. Brain . 2006

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部